Nombre del producto:4,4',4",4'"-(Pyrazino[2,3-g]quinoxaline-2,3,7,8-tetrayl)tetrabenzoic acid

IUPAC Name:4-[3,7,8-tris(4-carboxyphenyl)pyrazino[2,3-g]quinoxalin-2-yl]benzoic acid

CAS:2216715-50-1
Fórmula molecular:C38H22N4O8
Pureza:95%+
Número de catálogo:CM558723
Peso molecular:662.61

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2216715-50-1
Fórmula molecular:C38H22N4O8
Punto de fusión:-
Código de sonrisas:O=C(O)C1=CC=C(C2=NC3=CC4=NC(C5=CC=C(C=C5)C(O)=O)=C(C6=CC=C(C=C6)C(O)=O)N=C4C=C3N=C2C7=CC=C(C=C7)C(O)=O)C=C1
Densidad:
Número de catálogo:CM558723
Peso molecular:662.61
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.